5/29/2025Kanion's Generic Sumatriptan/Naproxen Gains Approval in China

5/29/2025China Approves Two New CDK4/6 Inhibitors for Advanced Breast Cancer

5/29/2025Merck Pursues Global Approvals for Pimicotinib Following Positive Phas...

5/29/2025Kelun-Biotech Initiates Phase 1 Trial for SKB571, a Bispecific ADC Tar...

5/29/2025Novartis Secures NMPA Approval for Beovu for DME in China

5/29/2025Minghui Advances IGF-1R Antibody MHB018A to Phase 3 for TED

5/27/2025Hengrui's c-MET-Targeted ADC SHR-1826 Shows Promising Results in Phase...

5/27/2025Eisai's Dayvigo Receives Approval in China for Insomnia

5/27/2025DualityBio's HER3-Targeted ADC DB-1310 Shows Promising Early Results i...

5/27/2025Salubris Pharma's S086 Receives Chinese Approval for Hypertension Trea...

5/27/2025RemeGen's Telitacicept Gains Approval in China

5/27/2025Juri Bio Secures Global Rights to Novel Prostate Cancer Immunotherapy ...

5/27/2025FDA Approves China's First Homegrown Painkiller Qamzova

5/27/2025Recce Pharma Secures Key China Patent

5/27/2025Servier Acquires BioNova's Menin Inhibitor BN104

5/27/2025Innovent's Mazdutide Demonstrates Significant Weight Loss in Phase 3 G...

5/27/2025Zai Lab's ZL-1310 Shows Promising Results in Extensive-Stage SCLC

5/27/2025Insilico Medicine Unveils AI-Designed ENPP1 Inhibitor ISM5939

5/27/2025Henlius Reports Promising Phase 1 Results for PD-L1-Targeting ADC HLX4...

5/27/2025CTTQ's Anlotinib Combination Shows Promise

5/23/2025Vigene and Merz Expand Strategic Partnership Across Greater China

5/23/2025CARsgen's Satri-cel CAR T Demonstrates Significant Efficacy in GC/GEJ

5/23/20253SBio's Bispecific Antibody SSGJ-707 Shows Promising Results in Advanc...

5/23/2025Dizal's DZD6008 Shows Promising Results in EGFR-Mutant NSCLC with Brai...

5/22/2025InnoVec Secures Series A Funding to Advance AI-Driven Gene Therapy Pla...

5/22/2025NMPA Approves Bayer's Eylea 8 mg for nAMD

5/22/2025China Approves Raynovent's Onradivir for Adult Influenza A Treatment

5/22/2025NMPA Grants Conditional Approval to JacoBio's Glecirasib for KRAS G12C...

5/21/2025Accropeutics Reports Phase 2 Psoriasis Success with TYK2/JAK1 Inhibito...

5/21/2025China Approves InnoCare's Tafasitamab for R/R DLBCL

Page:18/22 Total number of articles:647: [First][<<] [16] [17] [18] [19] [20] [>>] [End]